F Sestier

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

Dual Angiotensin Receptor and Neprilysin Inhibition as an Alternative to Angiotensin-Converting Enzyme Inhibition in Patients with Chronic Systolic Heart Failure: Rationale for and Design of the Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure Trial (PARADIGM-HF)

Synergy between publication and promotion: comparing adoption of new evidence in Canada and the United States

Effects of weekend admission and hospital teaching status on in-hospital mortality

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels

Use of Cardiac Procedures and Outcomes in Elderly Patients with Myocardial Infarction in the United States and Canada

Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women

Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations

Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes

Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

The Failing Heart — An Engine Out of Fuel

Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction

The Quality of Health Care Delivered to Adults in the United States

Are Metabolic Risk Factors One Unified Syndrome? Modeling the Structure of the Metabolic Syndrome X

Wound repair and regeneration

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

The metabolic syndrome

Bariatric Surgery

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes

Vasopeptidase Inhibitors, Neutral Endopeptidase Inhibitors, and Dual Inhibitors of Angiotensin-Converting Enzyme and Neutral Endopeptidase

Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction

Adrenomedullin (ADM) in the human forearm vascular bed: effect of neutral endopeptidase inhibition and comparison with proadrenomedullin NH₂‐terminal 20 peptide (PAMP)

Myocardial infarction patients in the 1990s—their risk factors, stratification and survival in Canada: The Canadian assessment of myocardial infarction (CAMI) study

Chronic Renal Failure after Transplantation of a Nonrenal Organ

A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease

Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus

The metabolic syndrome

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials

Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study

Global and societal implications of the diabetes epidemic

Renal function: the Cinderella of cardiovascular risk profile

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

The influence of pretreatment lew density lipoprotein cholesterol concentrations on the effect of hypocholesterolemic therapy on coronary atherosclerosis in angiographic trials

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

Congestive Heart Failure: Fifty Years of Progress

What We Talk About When We Talk About Fat

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

The Gly¹⁶→Arg¹⁶and Gln²⁷→Glu²⁷Polymorphisms of β₂-Adrenergic Receptor Are Associated with Metabolic Syndrome in Men

Inflammation, Atherosclerosis, and Coronary Artery Disease

Targeted Anticytokine Therapy and the Failing Heart

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes

Biomarkers in Heart Failure

Improvements in insulin sensitivity and β‐cell function (HOMA) with weight loss in the severely obese

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

Variation among Hospitals in Coronary-Angiography Practices and Outcomes after Myocardial Infarction in a Large Health Maintenance Organization

Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease

Myocarditis

ACC/AHA guidelines for coronary angiography11“ACC/AHA Guidelines for Coronary Angiography” was approved by the American College of Cardiology Board of Trustees in October 1998 and by the American Heart Association Science Advisory and Coordinating Committee in December 1998.22When citing this document, the American College of Cardiology and the American Heart Association request that the following format be used: Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SD, Pepine CJ, Watson RM. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol1999;33:1756–82433This document is available on the websites of the ACC (www.acc.org) and the AHA (www.americanheart.org). Reprints of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0164. To obtain a reprint of the shorter version (executive summary and summary of recommendations) published in the May 4, 1999, issue of Circulation, ask for reprint No. 71-0163. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

First Trimester Insulin Resistance and Subsequent Preeclampsia: A Prospective Study

Functional Arteries Grown in Vitro

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

First Trimester Insulin Resistance and Subsequent Preeclampsia: A Prospective Study

Mobilized bone marrow cells repair the infarcted heart, improving function and survival

Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques

Remarks About Postinfarction Prognosis in Light of the Experience With the Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico (GISSI) Trials

Design, rationale, and baseline characteristics of the Prospective Pravastatin Pooling (PPP) project—A combined analysis of three large-scale randomized trials: Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID), Cholesterol and Recurrent Events (CARE), and West of Scotland Coronary Prevention Study (WOSCOPS)

Sex differences in the management and long-term outcome of acute myocardial infarction. A statewide study. MIDAS Study Group. Myocardial Infarction Data Acquisition System.

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury

Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes

The impact of training informal health care providers in India: A randomized controlled trial

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

Inflammation and metabolism in tissue repair and regeneration

Alternatively activated macrophages determine repair of the infarcted adult murine heart

Does More Intensive Treatment of Acute Myocardial Infarction in the Elderly Reduce Mortality?

Comparison of Omapatrilat and Enalapril in Patients With Chronic Heart Failure

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

Weekend versus Weekday Admission and Mortality from Myocardial Infarction

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

ATP-sensitive potassium channel (K _ATP )–dependent regulation of cardiotropic viral infections

Cholesterol and recurrent events: A secondary prevention trial for normolipidemic patients

Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial

Broad Modulation of Tissue Responses (Immune Activation) by Celacade May Favorably Influence Pathologic Processes Associated with Heart Failure Progression

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial

A Comparison of Management Patterns after Acute Myocardial Infarction in Canada and the United States

Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels

Activation of neurohumoral systems following acute myocardial infarction

Metabolic syndrome X: a review.